Optimisation of insulin treatment of type 2 diabetes mellitus by Telecare assistance for self monitoring of blood glucose (SMBG).

Trial Profile

Optimisation of insulin treatment of type 2 diabetes mellitus by Telecare assistance for self monitoring of blood glucose (SMBG).

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Jun 2011

At a glance

  • Drugs Insulin glargine (Primary) ; Insulin glulisine (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms ELEONOR
  • Sponsors Sanofi
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 05 Jun 2009 Quality-of-life and treatment satisfaction results presented at ADA 2009.
    • 12 May 2009 Actual patient number (352) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top